Reducing low blood sugar emergencies in adults with Type 1 diabetes using mobile health technology.
Minimizing Hypoglycemia in Adults with Type 1 Diabetes through an Integrated Mobile Health and Continuous Glucose Monitoring System
This study is looking to help adults with Type 1 diabetes who use continuous glucose monitors by figuring out what beliefs might be getting in the way of treating low blood sugar, and then creating a helpful mobile app to give them real-time support and education.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11103180 on NIH RePORTER |
What this research studies
This research aims to understand and address the beliefs that prevent effective treatment of low blood sugar (hypoglycemia) in adults with Type 1 diabetes who use continuous glucose monitoring systems. By employing mixed methods, the study will identify specific beliefs that interfere with treatment and develop a mobile health intervention to provide real-time support and education to patients. The goal is to create a patient-centered approach that leverages technology to minimize the occurrence of dangerous hypoglycemic events.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have Type 1 diabetes and use continuous glucose monitoring systems.
Not a fit: Patients who do not have Type 1 diabetes or those who do not use continuous glucose monitoring systems may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the frequency of hypoglycemic emergencies in adults with Type 1 diabetes.
How similar studies have performed: Previous research has shown promise in using mobile health interventions to improve diabetes management, indicating that this approach may be effective.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Lin, Yu Kuei — University of Michigan at Ann Arbor
- Study coordinator: Lin, Yu Kuei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.